Antivirals Flashcards
1 step - Binds to CD4 receptor of CD4 + T cells
GP120
2 step - binds to CCR5/CXCR4 co receptor of T cells
GP120
3 step - binds to T cell membrane and causes fusion of virus and T cell followed by viral genome entry into the cell
GP41
Codes for p24 and p17 (core protein)
Gag
Reverse transcriptase, integrate, protease
Pol
Gp120, gp41 (entry)
Env
Competive inhibition of HIV 1 reverse transcriptase
NRTIs
Absent hydroxyl group at 3’
Inhibition of 3’-5’ PDE bond formation
Incorporation into growing viral DNA strand causes premature chain termination
Nucleosides needs phosphorylation by cellular enzymes to be activated
Mitochondrial toxicity
NRTIs
Less toxic
ADR - headache, nausea, neutropenia
Cytidine base
Lamivudine
No serious A/E: low affinity for human DNA polymerase
Fanconi like syndrome
Adenosine base
Tenofovir
Used during pregnancy and breastfeeding to reduce vertical infection Tx and prophylaxis of HIV Combined with NNRTI and PI Can cause anemia Tymidine base
Zidovudine
ADR acute pancreatitis and peripheral neuropathy
Tymidine base
Stavudine
ADR: acute pancreatitis, optic neuritis, diarrhea, peripheral neuropathy
Adenosine base
Didanosine
Hypersensitivity associated with HLA-B 57:01 allele
May cause delayed type 4 hypersensitivity ran
Guanosine base
Abacravir
Less toxic
SE: hyperpigmentation of palms and soles
Cytidine base
Emitricitabine
Bind directly and not phosphorylated by intracellular enzymes - resulting in allosteric inhibition preventing replication of DNA
Bind directly and allosteric inhibition of HIV reverse transcriptase
NNRTIs
SE: insomnia and nightmares, rash is freq. with all drugs - 1st 4wks Rx
NNRTIs - especially efavirenz
NNRTIs
Nevarapine
Elfavirenz
Delaviridine
Etravirine
Rilpivirine
Inhibit the aspartate protease protease in HIV
Inhibit cytochrome p450
Protease inhibitors “Navir”
Codes for production of HIV enzymes, resistance mechanism will be developed in varying genes
POL gene
SE: hyperglycemia in diabetes due to insulin resistance, lipodystrophy, paraesthesia, rash at therapeutic [ ]
Protease inhibitors
Need to process gag and pol polyproteins into mature HIV components
Aspartate protease
Protease inhibitor that may cause nephrolithiasis
Indinavir
Protease inhibitor has greatest cytochrome p450 inhibitory effect and boosts concentration of other protease inhibitors
Ritonavir
Protease inhibitor - least toxic and easily develops resistance
Saquinavir
Protease inhibitor causing indirect hyperbilirubinemia
Atazanavir
Maximal suppression of HIV replication and increase px’s CD4 + T cell count
Combo of PI or NNRTI with one or two NRTIs often recomm.
Used to prolong life and delay sx’s
HAART
1st line for HAART
Lamivudine
+ NRTI (tenofivir, emtricitabine)
+ NNRTI (efavirenz, rilpivirine, etravirine)
Boost regimen
Co admin low dose ritonavir with other anti HIV drugs increase plasma [ ] of drugs
Lopinavir is PI with low oral bioavailability
Lopinavir + ritonavir increase antiretroviral effect
Saquinavir + ritonavir - prolong QT
Viral co receptor antagonists - competes for binding at CCR5 co receptors (inhibits entry)
Not for CXCR4
Contra: end stage renal failure
Maraviroc
Binds gp41
Inhibits fusion of HIV to host CD4 cells
Causes local skin rxn, neutropenia, active against drug resistant HIV
Enfuvirtide
Integrate inhibitor
Block HIV encoded integrate preventing integration of virus DNA into host chromosome
Raltegravir and other “gavir”
Prototype, oral or IV
Guanosine nucleoside analog
Acyclovir
Inhibits viral DNA dependent polymerase
Triphosphate incorporates into replicating DNA - halting synthesis
Absence of thymidine kinase in a herpes strain confers resistance
Acyclovir
Treats serious HSV and VZV infection, neonatal infections
Acyclovir
ADR: dose dependent decrease GFR, interstitial nephritis crystalline nephropathy
Acyclovir
Metabolized to acyclovir
Improved bioavailability
DOC: herpes zoster
Valacyclovir
Metabolized to peniclovir
To for shingles and VZV
Famuclovir
Inhibits fusion between plasma membrane and HSV envelope
Topical, aliphatic alcohol
Docosanol
Thymidine analogs
Get incorporated into DNA - faulty DNA formed - breaks down easily
Faulty DNA - synthesis of wrong viral proteins - maturation of virus inhibited
Only topical use
Idoxuridine
Trifluridine
Use for herpes simplex - keratojunctivitus
Vaccine virus keratitis
SE: ocular iirritation, edema of lids, photophobia
Trifluidine
Converted to mono phosphate by virus encoded kinase UL97
Resistance: mutation in UL97 or DNA polymerase
Ganciclovir
TX severe CMV
Ganciclovir
ADR: high systemic toxicity - BM suppression, thrombocytopenia, increase crystalluria
Ganciclovir
Does not require phosphorylation by viral kinase - active against ganciclovir and acyclovir resistant CMV, HSV, VZV
Foscarnet
Inhibits viral DNA and RNA poly and reverse transcriptase
Foscarnet
ADR: high toxicity- nephrotoxic, hypocalemia, hypomagnesium
Foscarnet
ADR: high systemic toxicity - BM depression (phosphorylated by host cell)
Trifluridine
Phosphorylated by host cell (not viral kinase)
Active against acyclovir and ganciclovir resistant CMV, VZV, HSV
Cidofovir
ADR: nephrotoxicity, leading to proteinuria, azotemia, and metabolic acidosis
Cidofovir
Only against inf A virus
Blocks M2 proton ion ch of virus and inhibits uncoating of viral RNA
ADR: insominia, seizures and arrhythmias at high doeses, livedo reticularis (venous swelling due to capillary thrombi)
Contra- pregnancy
Amantadine
Rimantadine
Enzyme found on outer cell membrane of viral particles
Neuraminidase
Inhibits neuramindase, prevents release of virions
Covers inf A, B and avian infuenza
Used within 36-48 hour of onset
Oseltamivir
Zanamivir
Peramivir
immunomodulatory cytokines released from virus infected cells
interleukins upregulate their synthesis in infected cells
interferons
treats hep B and C, kaposi sarcoma from HHV8, condyloma accuminata caused by HPV
interferon alpha
may cause flu like syndrome, profound fatigue, myelosuppression with zidovudine, lupus
interferon alpha
guanosine nucleoside analog
inhibit GTP and viral RNA syn.
inhibits RNA dependent RNA poly and capping of mRNA
ribavirin
ADR: dose dependent hemolytic anemia, highly teratogenic
oral admin - HCV
indications: with interferon chronic hep C
Nebulized: RSV bronchiolitis
ribavirin
inhibits the NS5B RNA polymerase
tx hep C
sofosabuvir
NS3/4 protease inhibitors -
serine protease enzyme required for cleaving viral polypeptide into fxn units
simprevir
grazoprevir
pro drug, active against hep B
inhibits HBV DNA poly, itself gets incorporated and terminates DNA chain
ADR: sore throat, headache, weakness, AB pain, flu like syndrome, *nephrotoxicity and * lactic acidosis
adefovir dipiroxil
antibody to A antigen on RSV
palivizumab
NS5A inhibitor (Hep C1) inhibits vira replication, assembly and release
ledipasvir
provides cure for Hep C
ledipasvir + sofosabuvir alone or along with ribavirin and/or pedinterferons
guanosine nucleoside
inhibits HBV DNA poly: base priming, reverse transcription of - strand and synthesis of + strand
treats hep B
entecavir
tenofovir
lamivudine